GRO Biosciences

grobio.com

GRO Biosciences is pioneering the field of protein therapeutics through its GRO platform, which utilizes an expanded amino acid alphabet to create novel proteins with enhanced properties. The company focuses on addressing significant medical challenges, particularly in reversing autoimmunity and eliminating immunogenicity, by employing non-standard amino acids (NSAAs) in its therapeutic designs. With a strong foundation in synthetic biology and a team of world-renowned experts, GRO Biosciences is positioned to revolutionize treatment options and improve patient outcomes across various diseases, including diabetes and growth disorders. Their scalable and sustainable production process, combined with a robust pipeline of unique NSAA therapeutics, underscores their commitment to advancing healthcare solutions.